Open AccessAsymptomatic Hyperuricemia: Treatment Approaches According to the Risk of Cardiovascular and Renal Events
Author(s) -
Ж. Д. Кобалава,
E. Troitskaya
Publication year - 2021
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2020.12.n1158
Subject(s) - hyperuricemia , asymptomatic , medicine , disease , kidney disease , uric acid , intensive care medicine , population , cardiology , environmental health
Asymptomatic hyperuricemia (HU) is widespread in the population. Results of multiple studies have demonstrated independent associations between increased levels of uric acid and risk of arterial hypertension, cardiovascular diseases, and chronic kidney disease. HU is considered as an independent predictor of cardiovascular and all-cause mortality. Despite the extensive study of this issue, there is still no unified answer to questions regarding the necessity of urate-lowering therapy in asymptomatic HU, whereas results of studies on the effect of this therapy on outcomes of cardiovascular and kidney diseases are controversial. This review summarized the basic, currently available information on this issue.